Stockreport

Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options [Seeking Alpha]

Co-Diagnostics, Inc.  (CODX) 
US:NASDAQ Investor Relations: ir.codiagnostics.com/investor-relations
PDF “We were pleased to successfully complete the appeal and have our shares relisted, and we are now firmly focused on moving forward,” said Chairman & CEO Dwight Egan. [Read more]